The decision marks the largest acquisition ever for Johnson & Johnson, at $21.3 billion, according to a report from The Washington Post. Approximately 75 percent of eligible voters were present for the session.
The acquisition is still waiting on clearance from regulatory bodies in the United States and Europe. Pending approval, the deal could be closed by June 2012.
Related Articles on Orthopedic Device Companies:
Smith & Nephew Cuts 80 Jobs in Memphis for Restructuring
K2M Names Don O’Hearn Senior Vice President of Sales in the Americas
VertiFlex Completes Superion Interspinous Trial Enrollment
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
